Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Effective but cost-prohibitive drugs in breast cancer treatment: a clinician's perspective.

Bines J, Eniu A.

Cancer. 2008 Oct 15;113(8 Suppl):2353-8. doi: 10.1002/cncr.23837. Review.

2.

Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines.

Anderson BO, Shyyan R, Eniu A, Smith RA, Yip CH, Bese NS, Chow LW, Masood S, Ramsey SD, Carlson RW.

Breast J. 2006 Jan-Feb;12 Suppl 1:S3-15.

PMID:
16430397
3.

Overview of breast health care guidelines for countries with limited resources.

Anderson BO, Braun S, Carlson RW, Gralow JR, Lagios MD, Lehman C, Schwartsmann G, Vargas HI.

Breast J. 2003 May-Jun;9 Suppl 2:S42-50. Review.

PMID:
12713496
4.

Interpreting the economic literature in oncology.

Grusenmeyer PA, Wong YN.

J Clin Oncol. 2007 Jan 10;25(2):196-202. Review.

PMID:
17210940
5.

Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.

Okonkwo QL, Draisma G, der Kinderen A, Brown ML, de Koning HJ.

J Natl Cancer Inst. 2008 Sep 17;100(18):1290-300. doi: 10.1093/jnci/djn292. Epub 2008 Sep 9.

6.

Breast cancer issues in developing countries: an overview of the Breast Health Global Initiative.

Anderson BO, Jakesz R.

World J Surg. 2008 Dec;32(12):2578-85. doi: 10.1007/s00268-007-9454-z. Review.

PMID:
18283512
7.

Review of cost-effectiveness analyses in hormonal therapies in advanced breast cancer.

Benedict A, Brown RE.

Expert Opin Pharmacother. 2005 Sep;6(11):1789-801. Review.

PMID:
16144501
8.
9.

Guideline implementation for breast healthcare in low- and middle-income countries: breast healthcare program resource allocation.

Harford J, Azavedo E, Fischietto M; Breast Health Global Initiative Healthcare Systems Panel.

Cancer. 2008 Oct 15;113(8 Suppl):2282-96. doi: 10.1002/cncr.23841.

10.

Cost-effective treatment options in first-line therapy for advanced breast cancer in Japan.

Kondo M, Toi M.

Expert Rev Anticancer Ther. 2006 Feb;6(2):197-204. Review.

PMID:
16445372
11.

A proven and highly cost-effective method of early detection of breast cancer for developing countries.

Rebentisch DP, Rebentisch HD, Thomas K, Karat S, Jadhav AJ.

Radiother Oncol. 1995 Dec;37(3):246-8.

PMID:
8746595
12.

Breast cancer in limited-resource countries: health care systems and public policy.

Anderson BO, Yip CH, Ramsey SD, Bengoa R, Braun S, Fitch M, Groot M, Sancho-Garnier H, Tsu VD; Global Summit Health Care Systems and Public Policy Panel.

Breast J. 2006 Jan-Feb;12 Suppl 1:S54-69.

PMID:
16430399
13.

Breast cancer in limited-resource countries: diagnosis and pathology.

Shyyan R, Masood S, Badwe RA, Errico KM, Liberman L, Ozmen V, Stalsberg H, Vargas H, Vass L; Global Summit Diagnosis and Pathology Panel.

Breast J. 2006 Jan-Feb;12 Suppl 1:S27-37.

PMID:
16430396
14.

Exemestane: a review of its use in postmenopausal women with breast cancer.

Deeks ED, Scott LJ.

Drugs. 2009;69(7):889-918. doi: 10.2165/00003495-200969070-00007. Review.

PMID:
19441873
15.

The incidence of breast cancer: the global burden, public health considerations.

Forbes JF.

Semin Oncol. 1997 Feb;24(1 Suppl 1):S1-20-S1-35. Review.

PMID:
9045313
16.

A model to optimize public health care and downstage breast cancer in limited-resource populations in southern Brazil. (Porto Alegre Breast Health Intervention Cohort).

Caleffi M, Ribeiro RA, Duarte Filho DL, Ashton-Prolla P, Bedin AJ Jr, Skonieski GP, Zignani JM, Giacomazzi J, Franco LR, Graudenz M, Pohlmann P, Fernandes JG, Kivitz P, Weber B.

BMC Public Health. 2009 Mar 13;9:83. doi: 10.1186/1471-2458-9-83.

17.

Resource-sparing and cost-effective strategies in current management of breast cancer.

Munshi A.

J Cancer Res Ther. 2009 Apr-Jun;5(2):116-20. doi: 10.4103/0973-1482.52797.

18.

American Society of Clinical Oncology guidance statement: the cost of cancer care.

Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM Jr, Blum D, Ubel PA, Schnipper LE; American Society of Clinical Oncology.

J Clin Oncol. 2009 Aug 10;27(23):3868-74. doi: 10.1200/JCO.2009.23.1183. Epub 2009 Jul 6.

19.

Guidelines for improving breast health care in limited resource countries: the Breast Health Global Initiative.

Anderson BO, Carlson RW.

J Natl Compr Canc Netw. 2007 Mar;5(3):349-56. Review.

PMID:
17439764
20.

Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends.

Moreno-Aspitia A, Perez EA.

Clin Ther. 2009 Aug;31(8):1619-40. doi: 10.1016/j.clinthera.2009.08.005. Review.

PMID:
19808124
Items per page

Supplemental Content

Write to the Help Desk